Evaluating HeartLogic Management for Heart Failure Outcomes
Official title: Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes
Run by Herlev and Gentofte Hospital · NCT06099158 · Data updated 2026-11-12
This study tests if using HeartLogic technology to manage heart failure can help patients with implanted devices do better compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1428 (estimated) |
| Sponsor | Herlev and Gentofte Hospital Academic / other |
| Locations | 5 sites (Hellerup, Capital Region and 4 other locations) |
| Status | Recruiting |
| Started | May 31, 2024 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT06099158 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who have an implanted CRT-D or ICD device with HeartLogic capability.
✕Probably not a fit
Patients who are not compliant with remote monitoring or are not using a device with HeartLogic capability may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study assesses the impact of HeartLogic-guided management on clinical outcomes in patients with heart failure who have an implanted cardiac device. It is a pragmatic, registry-based, randomized controlled trial conducted in Denmark, where eligible patients will be randomly assigned to either HeartLogic-guided management or usual care. Patients in the HeartLogic group will receive alerts for evaluation and treatment decisions without mandatory in-person visits, while the control group will follow standard heart failure care. Data will be collected from nationwide health registries to evaluate the effectiveness of the intervention.
Why it matters
Potential benefit: If successful, this approach could lead to improved heart failure management and outcomes for patients with cardiac devices.
How similar studies have gone: Other studies have shown promise in using remote monitoring for heart failure management, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization 2. Age ≥18 years 3. Compliant with remote monitoring and not listed in the LATITUDE™ remote monitoring system as "not monitored" Exclusion Criteria: There are no specific exclusion criteria for the trial.
Where it's running
-
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
Hellerup, Capital Region, Denmark Recruiting -
Aarhus University Hospital
Aarhus, Denmark Recruiting -
Rigshospitalet
Copenhagen, Denmark Recruiting -
Odense University Hospital
Odense, Denmark Recruiting -
Zealand University Hospital
Roskilde, Denmark Recruiting
Study contacts
- Study coordinator: Frederik Holme Fussing, MD
- Email: frederik.holme.fussing@regionh.dk
- Phone: +4521547157
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.